Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 18
- DOI:
- 10.3760/cma.j.issn.0366-6999.2012.18.014
- Key Word:
- histone deacetylase inhibitors;human cervical cancer;apoptosis;DNA-methyltransferase 3B;Trichostatin A;DNA methyl transferase
Abstract： Background Histone deacetylase (HDAC) inhibitors are a group of small chemical molecules that inhibit histone deacetylase.At cell level,HDAC inhibitors have multiple biological effects such as cell cycle arrest,apoptosis,cell differentiation and auotophagy.At molecular level,HDAC inhibitors cause histone and nonhistone acetylation and induce gene expression.HDAC inhibitors are widely used in cancer therapy because of its function of inducing apoptosis.However,the mechanisms of apoptosis effect are not fully understood.TSA is a classical HDAC inhibitor and widely used in epigenetic and anti-cancer research.In this study,we selected Trichostatin A (TSA) to investigate the mechanisms of HDAC inhibitors apoptotic effect on cancer cells.Methods Cervical cancer cell lines such as Hela,Caski and normal human keratinocyte line HaCaT were treated with various concentrations of TSA.Crystal violent assay and 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay were performed to determine cell number.PARP cleavage and FITC-AnexinV were performed to determine apoptosis.DNA-methyltransferase (DNMT)1,DNMT3A and DNMT3B were determined by regular PCR,qPCR and Western Blotting.Small interfering RNA (SiRNAi) was used to knock down DNMT3B.Results HDAC inhibitors only induce cervical cancer cell apoptosis.At 1 μmol/L of TSA,86％ of Hela cell and 76％ of Caski went apoptosis.For normal cells,HDAC inhibitors have no cytotoxic effect at therapeutic dosage,(90.0±8.4)％ of normal cell survive after treated with 1 μmol/L of TSA.We compared 1 μmol/L group with untreated control with t-test.There was no significance between 1 μmol/L group and untreated control for normal cell (P ＞0.05).HDAC inhibitors decreased DNMT3B in cancer cell but not in normal cell.Manually knock-down of DNMT3B induced Hela and Caski cell apoptosis.More than 99％ of Hela and Caski cell went apoptosis after deprived of DNMT3B.Conclusions DNMT3B was essential to cervical cancer cell survival.Down-regulated DNMT3B by HDAC inhibitors may play an important role in the toxicity of HDAC inhibitors on cervical cancer cells.
- [1]R P, Warrell,L Z, He,V, Richon,etc.Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.[J].1998,90.
- [2]Arzenani, Mohsen Karimi,Zhang, Zhe,Vukojevic, Vladana,etc.Genomic DNA Hypomethylation by Histone Deacetylase Inhibition Implicates DNMT1 Nuclear Dynamics[J].2011,31(19).
- [3]Marks PA,Xu WS.Histone deacetylase inhibitors: Potential in cancer therapy.[J].2009,107(4).
- [4]Melnick A,Licht JD.Histone deacetylases as therapeutic targets in hematologic malignancies.[J].2002,9(4).
- [5]P, Marks,R A, Rifkind,V M, Richon,etc.Histone deacetylases and cancer: causes and therapies.[J].2001,1(3).
- [6]Caulfield T,Lyko F,Medina Franco JL,etc.Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells.[J].2010,9(11).
- [7]Marks PA,Kelly WK,Miller T,etc.Histone deacetylase inhibitors.[J].2004,91(0).
- [8]Jones PA,Baylin SB.The fundamental role of epigenetic events in cancer.[J].2002,3(6).
- [9]P P, Pandolfi.Histone deacetylases and transcriptional therapy with their inhibitors.[J].2001,48 Suppl 1.
- [10]Sakai T,Huang L,Pardee AB,etc.Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.[J].2000,19(50).
- [11]Sarkar S,Abujamra AL,Loew JE,etc.Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.[J].2011,31(9).
- [12]S. Timmermann,H. Lehrmann,A. Polesskaya,etc.Histone acetylation and disease[J].2001,58(5/6).
- [13]Redner RL,Liu JM,Wang J,etc.ETO, fusion partner in t(8; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.[J].1998,95(18).